We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.9B
AUM Growth
+$213M
(+5.8%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172
Avg Time Held Equity + Options
4.3
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
3.2
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$79.4M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$52M |
| 3 |
Apple
AAPL
|
+$6.85M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$6.48M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$5.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$52.1M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$44M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$9.53M |
| 4 |
NVIDIA
NVDA
|
+$4.49M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.08% |
| 2 | Technology | 16.58% |
| 3 | Healthcare | 8.56% |
| 4 | Financials | 6.53% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2726
Arrow Dow Jones Global Yield ETF
GYLD
$38.8M
| $2.52K | ﹤0.01% |
193
| – | – |
2020 Q2
16 quarters
|
|
2727
Iovance Biotherapeutics
IOVA
$6.17B
| $2.51K | ﹤0.01% |
313
+205
| +190% | +$2.2K |
2020 Q2
16 quarters
|
|
2728
BondBloxx High Yield Income ETF
HYSA
$107M
| $2.51K | ﹤0.01% |
169
| – | – |
2023 Q3
3 quarters
|
|
2729
Sturm, Ruger & Co
RGR
$677M
| $2.5K | ﹤0.01% |
60
-383
| -86% | -$17K |
2019 Q1
21 quarters
|
|
2730
JPMorgan US Value Factor ETF
JVAL
$1.01B
| $2.49K | ﹤0.01% |
+61
| New | +$2.47K |
2024 Q2
0 quarters
|
|
2731
DELISTED
NEVRO CORP.
NVRO
| $2.49K | ﹤0.01% |
296
+223
| +305% | +$2.38K |
2023 Q3
3 quarters
|
|
2732
Cass Information Systems
CASS
$695M
| $2.48K | ﹤0.01% |
62
-58
| -48% | -$2.53K |
2016 Q4
30 quarters
|
|
2733
First Trust Dividend Strength ETF
FTDS
$39.2M
| $2.48K | ﹤0.01% |
51
| – | – |
2023 Q4
2 quarters
|
|
2734
Red Rock Resorts
RRR
$2.96B
| $2.47K | ﹤0.01% |
45
| – | – |
2022 Q4
6 quarters
|
|
2735
Twist Bioscience
TWST
$8.8B
| $2.46K | ﹤0.01% |
50
+27
| +117% | +$1.1K |
2021 Q2
12 quarters
|
|
2736
Fulgent Genetics
FLGT
$558M
| $2.45K | ﹤0.01% |
125
-68
| -35% | -$1.42K |
2021 Q1
13 quarters
|
|
2737
Veracyte
VCYT
$3.55B
| $2.45K | ﹤0.01% |
113
| – | – |
2022 Q2
8 quarters
|
|
2738
Novanta
NOVT
$4.97B
| $2.45K | ﹤0.01% |
15
-31
| -67% | -$5.03K |
2021 Q3
11 quarters
|
|
2739
APi Group
APG
$17.4B
| $2.45K | ﹤0.01% |
98
-300
| -75% | -$7.53K |
2021 Q4
10 quarters
|
|
2740
NeoGenomics
NEO
$2.14B
| $2.44K | ﹤0.01% |
176
-29
| -14% | -$411 |
2021 Q1
13 quarters
|
|
2741
Oscar Health
OSCR
$10.1B
| $2.44K | ﹤0.01% |
154
+54
| +54% | +$992 |
2022 Q2
8 quarters
|
|
2742
Dauch Corp
DCH
$1.18B
| $2.42K | ﹤0.01% |
346
+177
| +105% | +$1.3K |
2021 Q2
12 quarters
|
|
2743
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.67B
| $2.42K | ﹤0.01% |
74
| – | – |
2022 Q2
8 quarters
|
|
2744
Copa Holdings
CPA
$5.45B
| $2.4K | ﹤0.01% |
25
| – | – |
2020 Q2
16 quarters
|
|
2745
The GEO Group
GEO
$3.76B
| $2.4K | ﹤0.01% |
167
| – | – |
2024 Q1
1 quarter
|
|
2746
Agilysys
AGYS
$3.12B
| $2.4K | ﹤0.01% |
23
+2
| +10% | +$179 |
2022 Q3
7 quarters
|
|
2747
Edgewise Therapeutics
EWTX
$4.02B
| $2.4K | ﹤0.01% |
133
+38
| +40% | +$663 |
2023 Q4
2 quarters
|
|
2748
Artivion
AORT
$1.06B
| $2.38K | ﹤0.01% |
93
| – | – |
2022 Q3
7 quarters
|
|
2749
Appian
APPN
$2.98B
| $2.38K | ﹤0.01% |
77
| – | – |
2018 Q3
23 quarters
|
|
2750
Vitesse Energy
VTS
$761M
| $2.37K | ﹤0.01% |
100
| – | – |
2023 Q1
5 quarters
|
|
Similar funds
Parallel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
- Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
- Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
- Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
- Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
- Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.
Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.